[1]
Nagai M, Imai Y, Wada Y, Kusakabe M, Yamanishi K. Serum Procalcitonin and Presepsin Levels in Patients with Generalized Pustular Psoriasis. Disease markers. 2018:2018():9758473. doi: 10.1155/2018/9758473. Epub 2018 Dec 16
[PubMed PMID: 30647802]
[2]
Peccerillo F, Odorici G, Ciardo S, Conti A, Pellacani G. Evaluation of generalized pustular psoriasis by reflectance confocal microscopy. Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI). 2019 May:25(3):402-403. doi: 10.1111/srt.12655. Epub 2019 Jan 5
[PubMed PMID: 30614082]
[3]
Akiyama M. Early-onset generalized pustular psoriasis is representative of autoinflammatory keratinization diseases. The Journal of allergy and clinical immunology. 2019 Feb:143(2):809-810. doi: 10.1016/j.jaci.2018.11.009. Epub 2019 Jan 1
[PubMed PMID: 30606494]
[4]
Meier-Schiesser B,Feldmeyer L,Jankovic D,Mellett M,Satoh TK,Yerly D,Navarini A,Abe R,Yawalkar N,Chung WH,French LE,Contassot E, Culprit Drugs Induce Specific IL-36 Overexpression in Acute Generalized Exanthematous Pustulosis. The Journal of investigative dermatology. 2018 Nov 2;
[PubMed PMID: 30395846]
[5]
Li L, You J, Fu X, Wang Z, Sun Y, Liu H, Zhang F. Variants of CARD14 are predisposing factors for generalized pustular psoriasis (GPP) with psoriasis vulgaris but not for GPP alone in a Chinese population. The British journal of dermatology. 2019 Feb:180(2):425-426. doi: 10.1111/bjd.17392. Epub 2018 Nov 29
[PubMed PMID: 30387497]
[6]
Twelves S, Mostafa A, Dand N, Burri E, Farkas K, Wilson R, Cooper HL, Irvine AD, Oon HH, Kingo K, Köks S, Mrowietz U, Puig L, Reynolds N, Tan ES, Tanew A, Torz K, Trattner H, Valentine M, Wahie S, Warren RB, Wright A, Bata-Csörgő Z, Szell M, Griffiths CEM, Burden AD, Choon SE, Smith CH, Barker JN, Navarini AA, Capon F. Clinical and genetic differences between pustular psoriasis subtypes. The Journal of allergy and clinical immunology. 2019 Mar:143(3):1021-1026. doi: 10.1016/j.jaci.2018.06.038. Epub 2018 Jul 21
[PubMed PMID: 30036598]
[7]
Ho PH, Tsai TF. Successful treatment of refractory juvenile generalized pustular psoriasis with secukinumab monotherapy: A case report and review of published work. The Journal of dermatology. 2018 Nov:45(11):1353-1356. doi: 10.1111/1346-8138.14636. Epub 2018 Sep 19
[PubMed PMID: 30230584]
Level 3 (low-level) evidence
[8]
Boehner A, Navarini AA, Eyerich K. Generalized pustular psoriasis - a model disease for specific targeted immunotherapy, systematic review. Experimental dermatology. 2018 Oct:27(10):1067-1077. doi: 10.1111/exd.13699. Epub 2018 Jul 20
[PubMed PMID: 29852521]
Level 1 (high-level) evidence
[9]
Zhou LL, Georgakopoulos JR, Ighani A, Yeung J. Systemic Monotherapy Treatments for Generalized Pustular Psoriasis: A Systematic Review. Journal of cutaneous medicine and surgery. 2018 Nov/Dec:22(6):591-601. doi: 10.1177/1203475418773358. Epub 2018 Apr 30
[PubMed PMID: 29707979]
Level 1 (high-level) evidence
[10]
Hoegler KM, John AM, Handler MZ, Schwartz RA. Generalized pustular psoriasis: a review and update on treatment. Journal of the European Academy of Dermatology and Venereology : JEADV. 2018 Oct:32(10):1645-1651. doi: 10.1111/jdv.14949. Epub 2018 Apr 11
[PubMed PMID: 29573491]